|Day Low/High||117.52 / 119.92|
|52 Wk Low/High||35.83 / 120.99|
Going into earnings what the market needs now is more negativity, Cramer says.
Adam Feuerstein compiles a list of questions, thoughts, declarations, catalysts and observations about biotech stocks to help investors prepare for the year ahead.
The Canadian marijuana market is poised for growth as the number of registered patients continues grows and as licensed producers find innovative ways to create value for its shareholders.
GW Pharmaceuticals has developed cannabis-based therapies for treating epilepsy and multiple sclerosis.
Stocks enjoyed another strong day on Wall Street as the financial sector pushed the S&P 500 higher.
The Dow trades at an all-time high Monday as the financial and energy sectors rise.
The Dow trades at an all time high Monday as crude oil climbs higher and markets shrug off potential negative effects of Italy's 'no' vote on its constitutional reform referendum.
Stock futures rise Monday as crude oil continues to climb higher and markets shrug off potential negative effects of Italy's 'no' vote on its constitutional reform referendum.
Wall Street is looking at a quieter coming week with just a trickle of economic data to analyze before the Federal Reserve meeting on Dec. 13-14.
The British-based pharmaceutical company offers one of the best plays for investing in the growing legal marijuana industry.
The U.S. president elect has said in the past that he favors the legalization of marijuana, and he is unlikely to change his stance significantly.
Volatility in the stock markets should not be feared by investors, because any large gains or losses are often reversed after the panic or euphoria subsides.
Cannabis stocks listed on the Nasdaq continued to rally after voters ended prohibition and approved the recreational use of marijuana in California, Massachusetts, Maine and Nevada.
The volume of cannabis stocks listed on the Nasdaq have spiked ahead of the election as voters decide tomorrow on recreational and medical use of marijuana.
Jim Cramer says JCP is better, but 'just OK,' and investors should be careful with CEMP.
Jim Cramer says the market can have many winners.
Legalization of marijuana for medical reasons or otherwise is already on the ballot in Arkansas, California, North Dakota and several other states.
Marijuana is on the ballot in several states this election cycle, and its approval could be a boon for those in the business -- though obstacles remain.
Shares of these cannabis companies are ready for huge growth if November is a successful month for legalization.
The company's share price has increased 1,500% since 2013.
Company will request support from Colombia's Ministry of Health.
But the buyers are still unable to produce sustained momentum.